Clinical Evaluation of Safety and Efficacy of Vedistry Arjuna + Tablet in Hyperlipidemia
Abstract
Objective: To establish the efficacy and safety of Vedistry Arjuna + Tablet in the management of hyperlipidemia.
Methods: A randomized, double blind, active controlled, single center, clinical study was carried out using Vedistry Arjuna + Tablet for the duration of 12 weeks in 300 patients with hyperlipidemia and chronic stable angina.
Results: The results showed that Vedistry Arjuna + Tablet and Simvastatin both produced significant reduction of cholesterol and triglycerides. In addition, the group receiving Vedistry Arjuna + Tablet reported significant improvements in the stress test parameters compared to those receiving Simvastatin. Low incidences of side-effects in the Vedistry Arjuna + Tablet receiving group compared to Simvastatin receiving group indicates that Arjuna would be a safer alternative.
Conclusion: These findings suggest that Vedistry Arjuna + Tablet possesses antihyper-lipidemic, antihypertensive, and cardiac function improving activities.
Downloads
References
Yu C., Moore B.M., Kotchetkova I., Cordina R.L., Celermajer D.S. Causes of death in a contemporary adult congenital heart disease cohort. Heart. 2018;104:1678-1682. doi:10.1136/heartjnl-2017-312777.
Cardiovascular Diseases (CVDs) - World Health Organization. [(accessed on 19 September 2021)]. Available online: https://www.euro.who.int/en/health-topics/noncommunicable-diseases/cardiovascular-diseases/cardiovascular-diseases2/definition-of-cardiovascular-diseases.
Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982-3021.
Banach M, Surma S, Toth PP; endorsed by the International Lipid Expert Panel (ILEP). 2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024? Arch Med Sci. 2023 Nov 2;19(6):1602-1615. doi:10.5114/aoms/174743. PMID:38058712; PMCID:PMC10696981.
Singh BB, Vinjamury SP, et al. Ayurvedic and collateral herbal treatments for hyperlipidemia: A systematic review of randomized controlled trials and quasi-experimental designs. Altern Ther Health Med. 2007;13(4):22-28.
Shridhar Dwivedi, Deepti Chopra. Revisiting Terminalia arjuna - An ancient cardiovascular drug. J Tradit Complement Med. 2014;4(4):224-231.
Dwivedi S. Terminalia arjuna Wight and Arn.—A useful drug for cardiovascular disorders. J Ethnopharmacol. 2007;1:114-129.
Bharani A, Ganguli A, Mathur LK, Jamra Y, Raman PG. Efficacy of Terminalia arjuna in chronic stable angina: A double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Indian Heart J. 2002;54:170-175.
Gotto AM Jr, LaRosa JC, Hunninghake D, et al. The cholesterol facts: A summary of the evidence relating dietary facts, serum cholesterol, and coronary heart disease. Circulation. 1990;81:1721-1733.
Buchwald H, Varco RL, Matts JP, et al. Effect of partial ileal bypass on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: Report of the Program on the Surgical Control of Hyperlipidemias (POSCH). N Engl J Med. 1990;323:946-955.
Pyorala K, De Becker G, Graham I, on behalf of the Task Force. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society, and European Society of Hypertension. Eur Heart J. 1994;15:1300-1331.
Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10;140(11):e596-e646. doi:10.1161/CIR.0000000000000678. PMID:30879355.
Lardizabal JA, Deedwania PC. The anti-ischemic and anti-anginal properties of statins. Curr Atheroscler Rep. 2011 Feb;13(1):43-50. doi:10.1007/s11883-010-0147-y. PMID:21107759; PMCID:PMC3018271.
Cheon DY, Jo SH. Adverse effects of statin therapy and their treatment. Cardiovasc Prev Pharmacother. 2022;4(1):1-6.
Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of Iranian medicinal plants useful in diabetes mellitus. Arch Med Sci. 2008;4(3):285-292.
Shridhar Dwivedi, Deepti Chopra. Revisiting Terminalia arjuna - An ancient cardiovascular drug. J Tradit Complement Med. 2014;4(4):224-231.
Anjali MR, et al. Piperine as a bioavailability enhancer: A review. Asian J Pharm Anal Med Chem. 2017;5(1):44-48.
Copyright (c) 2025 Dnyaneshwar Mote, Sandip Mali
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
